Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Activation of the Adrenomedullin Receptors in Migraine: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

NCT07451769 is registered in ClinicalTrials.gov with Danish Headache Center as lead sponsor.

NCT NCT07451769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07451769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Activation of the Adrenomedullin Receptors in Migraine: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
Lead sponsor
Danish Headache Center
Phase
Not applicable
Overall status
Recruiting
Start date
March 12, 2026
Completion date
December 20, 2032
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenomedullin, brain diseases, central nervous system diseases, migraine, neuropeptides, pain, peptides, signs and symptoms